Name: UTHR Income Statement - United Therapeutics Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

UTHR - United Therapeutics Corp.

USD | NASDAQ | Healthcare

UTHR Income Statement - United Therapeutics Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	781.5	790.2	799.5	798.6	794.4	735.9	748.9	714.9	677.7	614.7	609.4	596.5	506.9	491.5	516.0	466.9

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	3,169.8	3,182.7	2,877.4	2,327.5	1,936.3	1,685.5	1,483.3	1,448.8	1,627.8	1,725.3	1,598.8	1,465.8	1,288.5	1,117.0	916.1	743.2	592.9	358.9
Cost of Revenue	425.3	384.4	309.7	257.5	151.6	122.5	108.1	117.6	198.7	105.7	72.7	69.0	125.9	131.1	119.3	88.9	67.7	40.9
Gross Profit	2,744.5	2,798.3	2,567.7	2,070.0	1,784.7	1,563.0	1,375.2	1,331.2	1,429.1	1,619.6	1,526.1	1,396.8	1,162.6	985.9	796.8	654.3
Operating Expenses
Research & Development	539.2	550.0	481.0	408.0	322.9	540.1	357.7	1,182.6	357.9	264.6	147.6	245.1	242.5	299.3	173.4
Operating Income
Operating Income	1,435.5	1,492.5	1,377.0	1,184.9	979.7	555.9	593.6	(187.6)	805.4	814.9	1,061.7	699.0	538.8	292.5
Non-Operating
Interest Income	182.7	192.0	199.1	162.7	45.2	16.7	28.6	44.2	28.6	10.9	3.5	-	-	3.8	3.9
Tax & Net
Income Tax Expense	321.3	379.2	343.9	289.5	223.3	118.1	124.1	(60.5)	169.7	351.6	346.5	392.8	185.1	104.3	136.2
Per Share
EPS Basic	29.60	30.13	26.44	21.04	15.98	10.60	11.65	(2.39)	13.54	9.50	16.29	14.17	7.06	3.49	5.84	3.81
Supplementary Data
EBITDA	-	1,578.1	1,449.5	1,238.1	1,031.0	605.8	643.5	(141.7)	841.3	845.9	1,093.3	731.9	571.0	323.8	448.8	338.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	138.2	139.5	127.5	134.0	149.0	133.8	103.5	139.6	104.1	151.4	84.7	89.0	82.9	93.9	66.1	93.9	69.0	82.9	79.2	74.3	303.7	126.1	68.7	89.7	73.2	113.6	85.7	85.9	897.4	138.8	101.1	82.3	35.7	-	-	-	-	-	45.9	-
Selling General & Administrative	184.1	190.6	182.6	212.5	170.1	168.5	219.2	177.6	144.4	132.2	127.6	130.0	87.3	163.2	98.4	141.5
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	22.6	-	-	-	19.8	-	-	-	15.0	-	-	-	13.3	-	-	-
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	455.7	433.5	411.0	434.1	411.6	378.2	405.8	395.0	321.4	354.6	282.4	283.1	222.5	315.9	201.7	265.1

Operating Income
Operating Income	325.8	356.7	388.5	364.5	382.8	357.7	343.1	319.9	356.3	260.1	327.0	313.4	284.4	175.6	314.3	201.8	288.0	169.8	228.7	222.2	(64.8)	65.3	221.1	140.5	166.7	63.5	183.4	221.4	(655.9)	131.5	149.6	217.4	306.9	139.0	323.8	88.5	263.6	174.2	238.6	285.2

Non-Operating
Interest Income	41.8	43.2	46.4	51.3	51.1	49.3	49.8	46.2	53.8	51.0	45.3	37.2	29.2	20.8	13.3	6.8	4.3	4.2	3.8	4.0	4.7	5.0	6.4	7.2	10.0	11.5	12.1	10.8	9.8	8.7	7.9	6.7	5.3	-	2.2	-	-	-	-	-
Interest Expense	3.0	3.1	3.0	7.3	6.1	7.9	10.1	11.6	13.3	15.1	15.6	14.8	13.8	12.3	9.2	6.2	4.7	4.7
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(7.5)	87.3	49.5	43.9	40.7	38.8	45.5	35.4	42.3	35.3	24.8	21.8	7.5	3.2	(1.8)	(51.2)	20.7
Pre-Tax Income	318.3	444.0	438.0	408.4	423.5	396.5	388.6	355.3	398.6	295.4	351.8	335.2	291.9	178.8	312.5	150.6

Tax & Net
Income Tax Expense	43.4	79.7	99.3	98.9	101.3	95.2	79.5	77.2	92.0	78.3	84.2	76.0	51.0	46.7	73.2	34.6	68.8	28.3	41.7	43.9	4.2	15.6	47.8	26.8	33.9	15.7	34.5	45.3	(156.0)	26.6	33.6	45.0	64.5	122.0	44.4	100.2	85.0	61.2	77.3	79.6
Net Income From Continuing Ops	274.9	364.3	338.7	309.5	322.2	301.3	309.1	278.1	306.6	217.1	267.6	259.2	240.9	132.1	239.3	116.0	239.9
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	274.9	364.3	338.7	309.5	322.2	301.3	309.1	278.1	306.6	217.1	267.6	259.2	240.9	132.1	239.3	116.0	239.9
Net Income Attributable To Parent	274.9	364.3	338.7	309.5	322.2	301.3	309.1	278.1	306.6	217.1	267.6	259.2	240.9	132.1	239.3	116.0
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	274.9	364.3	338.7	309.5	322.2	301.3	309.1	278.1	306.6	217.1	267.6	259.2	240.9	132.1	239.3

Per Share
EPS Basic	6.32	-	7.73	6.86	7.18	-	6.93	6.26	6.52	-	5.71	5.53	5.20	-	5.26	2.56	5.31	-	3.62	3.85	0.63	-	3.86	2.43	3.14	-	3.02	4.68	(11.32)	-	2.44	4.01	5.65	-	6.37	(1.25)	4.01	-	3.75	4.65
EPS Diluted	5.82	-	7.16	6.41	6.63	-	6.39	5.85	6.17	-	5.38	5.24	4.86	-	4.91	2.41	5.03	-
Shares Basic	43.5	-	43.8	45.1	44.9	-	44.6	44.4	47.0	-	46.9	46.9	46.3	-	45.5	45.4	45.2	-
Shares Diluted	47.2	-	47.3	48.3	48.6	-	48.4	47.5	49.7	-	49.7	49.5	49.6	-	48.7	48.1	47.7	-

Supplementary Data
EBITDA	348.4	-	-	-	402.6	-	-	-	371.3	-	-	-	297.7	-	-	-	300.5	-	-	-	(52.3)	-	-	-	179.1	-	-	-	(645.6)	-	-	-	314.8	-	-	-	271.5	-	-	-
EBIT	325.8	356.7	388.5	364.5	382.8	357.7	343.1	319.9	356.3	260.1	327.0	313.4	284.4	175.6	314.3	201.8	288.0	169.8	228.7